In a recent article by AgFunderNews, they discuss how the cannabis industry's legalization progress is also causing increased scrutiny to comply with regulations, despite the roadblocks caused by the COVID-19 pandemic. Read an excerpt from the article below:
"'It's a unique set of circumstances because cannabis businesses are required to comply with all of the new laws and employment regulations coming into play but are not eligible for any of the support the CARES Act provides. It's a double whammy,' [Dr.] Jonathan Vaught, co-founder and CEO of Front Range Biosciences, told AFN.
"Through its Clean Stock program, Front Range Biosciences specializes in tissue culture propagation at industrial scale to ensure that it offers hemp and cannabis growers pest and disease-free stock. It also maintains a varietal development program to address some of growers' biggest challenges like drought tolerance, pest tolerance, and overall hardiness.
"Given its newfound stature, the industry is also feeling the pandemic's impact on daily operations. Social distancing requirements, heightened sanitation protocols, and delays in logistics are impacting it the same way they're impacting other segments of agriculture."
Read the full article here.
- Searching for cannabinoid-rich hemp plants? To view our current availability for cannabinoid-rich clones from our Clean Stock® program, as well as our seedlings and feminized seeds, contact our sales team at: firstname.lastname@example.org or complete an order inquiry at: https://www.frontrangebio.com/inquire
- Stay up-to-date with FRB’s current events and information by following our Resources page